- Home
- ALDX vs OGI Comparison
ALDX vs OGI Comparison
Compare ALDX & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- OGI
- Stock Information
- Founded
- ALDX 2004
- OGI 2013
- Country
- ALDX United States
- OGI Canada
- Employees
- ALDX N/A
- OGI N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- ALDX Health Care
- OGI Health Care
- Exchange
- ALDX Nasdaq
- OGI Nasdaq
- Market Cap
- ALDX 160.8M
- OGI 155.2M
- IPO Year
- ALDX 2014
- OGI N/A
- Fundamental
- Price
- ALDX $3.05
- OGI $1.29
- Analyst Decision
- ALDX Strong Buy
- OGI
- Analyst Count
- ALDX 2
- OGI 0
- Target Price
- ALDX $9.50
- OGI N/A
- AVG Volume (30 Days)
- ALDX 769.8K
- OGI 528.0K
- Earning Date
- ALDX 07-31-2025
- OGI 08-12-2025
- Dividend Yield
- ALDX N/A
- OGI N/A
- EPS Growth
- ALDX N/A
- OGI N/A
- EPS
- ALDX N/A
- OGI 0.10
- Revenue
- ALDX N/A
- OGI $135,031,829.00
- Revenue This Year
- ALDX N/A
- OGI $50.30
- Revenue Next Year
- ALDX N/A
- OGI $16.01
- P/E Ratio
- ALDX N/A
- OGI $12.75
- Revenue Growth
- ALDX N/A
- OGI 20.49
- 52 Week Low
- ALDX $1.14
- OGI $0.85
- 52 Week High
- ALDX $7.20
- OGI $2.08
- Technical
- Relative Strength Index (RSI)
- ALDX 61.89
- OGI 45.78
- Support Level
- ALDX $2.60
- OGI $1.30
- Resistance Level
- ALDX $3.24
- OGI $1.51
- Average True Range (ATR)
- ALDX 0.22
- OGI 0.05
- MACD
- ALDX 0.09
- OGI -0.02
- Stochastic Oscillator
- ALDX 80.93
- OGI 4.44
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.